Source: Eur Respir J, 51 (3) 1800103; 10.1183/13993003.00103-2018
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Xiaofeng Zhou, Bethany B. Moore. Location or origin? What is critical for macrophage propagation of lung fibrosis?. Eur Respir J, 51 (3) 1800103; 10.1183/13993003.00103-2018

Member's Comments

No comment yet.

Related content which might interest you: The fate of lung fibrosis: Reversible or not? Source: Lung Science Conference 2008 - Lung Injury, Repair and Remodelling Year: 2008 Cellular plasticity in lung fibrosis: where are all the fibroblasts coming from? Source: Annual Congress 2012 - PG11 Pulmonary fibrosis Year: 2012 Monitoring early lung disease in cystic fibrosis: where are we now? Source: Breathe 2014; 10: 34-47 Year: 2014 Regulation of immune cells in lung fibrosis: the reign of regnase-1? Source: Eur Respir J, 57 (3) 2004029; 10.1183/13993003.04029-2020 Year: 2021 Making the case for causality: what role do lung microbiota play in idiopathic pulmonary fibrosis? Source: Eur Respir J, 55 (4) 2000318; 10.1183/13993003.00318-2020 Year: 2020 Regulation of alternative macrophage activation by galectin-3; potential role in lung fibrosis Source: Annual Congress 2009 - What is new in molecular pathology and functional genomics of neoplastic and non-neoplastic lung disease? Year: 2009 What defines abnormal lung function? Source: Annual Congress 2009 - Natural history of COPD Year: 2009 Role of macrophage activation in type II alveolar cells transplantation for the treatment of idiopathic pulmonary fibrosis Source: Annual Congress 2013 –Translational studies in chronic repair and remodelling in the lung Year: 2013 Treatment of early lung disease – is it possible? Does it work? Source: Annual Congress 2004 - PG19 - Screening for cystic fibrosis: diagnose early - treat early Year: 2004 Lung inflammation in cystic fibrosis: an overlooked therapeutic target? Source: Virtual Congress 2020 – Cystic fibrosis: from cradle to old age Year: 2020 A role for cathepsin S in the pathogenesis of cystic fibrosis lung disease? Source: Annual Congress 2011 - Cell biology of lung disease Year: 2011 Impact of pulmonary vascular volume on mortality in IPF: is it time to reconsider the role of vasculature in disease pathogenesis and progression? Source: Eur Respir J , 49 (2) 1602345; DOI: 10.1183/13993003.02345-2016 Year: 2017 Impact of pulmonary vascular volume on mortality in IPF: is it time to reconsider the role of vasculature in disease pathogenesis and progression? Source: Eur Respir J , 49 (2) 1602524; DOI: 10.1183/13993003.02524-2016 Year: 2017 Role of neutrophil mechanisms of inflammation in pathogenesis of different types of pulmonary fibrosis Source: Eur Respir J 2003; 22: Suppl. 45, 459s Year: 2003 Opening Lecture: Is human pulmonary fibrosis simply lung regeneration without a blueprint? Source: ERS Lung Science Conference 2021 Year: 2021 Does apoptosis evasion only affect fibroblasts from idiopathic pulmonary fibrosis? Source: Annual Congress 2013 –Cell signalling and inflammation: what's new in 2013? Year: 2013 Oxidative stress in cystic fibrosis lung disease: an early event, but worth targeting? Source: Eur Respir J 2014; 44: 17-19 Year: 2014 Is toll like receptor 4 a common pathway hypothesis for development of lung cancer and idiopathic pulmonary fibrosis? Source: International Congress 2016 – IPF: from pathogenesis to treatment II Year: 2016 The GPx1-PTP1B-PP2A axis: A key determinant of airway inflammation and alveolar destruction Source: Annual Congress 2013 –Acute lung injury: novel clinical and experimental insights Year: 2013